# Sublingual Immunotherapy for Peanut Allergy and Induction of Tolerance

> **NCT01373242** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 54 (actual)

## Conditions studied

- Peanut Hypersensitivity
- Food Hypersensitivity
- Food Allergy
- Peanut Allergy

## Interventions

- **DRUG:** Liquid peanut extract (Peanut SLIT)

## Key facts

- **NCT ID:** NCT01373242
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2018-04-16
- **Final completion:** 2018-04-16
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2019-06-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01373242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01373242, "Sublingual Immunotherapy for Peanut Allergy and Induction of Tolerance". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01373242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*